Treats hypertension. ANDA 70886, held by Aurobindo Pharma Ltd. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 70886 (Clonidine Hydrochloride), held by Aurobindo Pharma Ltd, was first approved by FDA on Aug 31, 1988, with 4 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension. Clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1988 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.2MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.3MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Mar 25, 1998 | Supplement 5Labeling | Approved | None posted |
| Mar 2, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Feb 1, 1995 | Supplement 4Manufacturing | Approved | None posted |
| Mar 4, 1992 | Supplement 3Manufacturing | Approved | None posted |
| Aug 31, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters